PALIVIZUMAB FOR PROPHYLAXIS AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN CHILDREN WITH CYSTIC FIBROSIS: RESULTS OF A COCHRANE SYSTEMATIC REVIEW

被引：0
|
作者：
Saldanha, I. [1 ]
Mckoy, N. A. [1 ]
Robinson, K. A. [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
来源：
PEDIATRIC PULMONOLOGY | 2010年
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：331 / 331
页数：1
相关论文
共 50 条
  • [31] Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV)
    Geskey, Joseph M.
    Thomas, Neal J.
    Brummel, Gretchen L.
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (01): : 33 - 43
  • [32] Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection
    Caserta, Mary T.
    O'Leary, Sean T. R.
    Munoz, Flor M. M.
    Ralston, Shawn L.
    PEDIATRICS, 2023, 152 (01)
  • [33] Efficacy and long-term outcomes of palivizumab prophylaxis to prevent respiratory syncytial virus infection in infants with cystic fibrosis in Northern Ireland
    Groves, H. E.
    Jenkins, L.
    Macfarlane, M.
    Reid, A.
    Lynn, F.
    Shields, M. D.
    PEDIATRIC PULMONOLOGY, 2016, 51 (04) : 379 - 385
  • [34] The Prevention of Respiratory Syncytial Virus Infection in Children: Focus on Palivizumab
    Speer, Michael E.
    Good, Amy B.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 459 - 469
  • [35] Does prophylaxis with palivizumab reduce hospitalisation rates for respiratory-syncytial-virus-related infection in cystic fibrosis children less than 2 years of age?
    Elnazir, Basil
    Oni, Oluwole
    Hassan, Taha
    Greally, Peter
    Paes, Bosco
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2012, 48 (11) : 1033 - 1038
  • [36] Emotional and time costs of respiratory syncytial virus prophylaxis: Comparing palivizumab to RSV-IG
    Robbins, JM
    Tilford, JM
    Gillaspy, SR
    Simpson, DD
    Wheeler, JG
    Shaw, JL
    Jacobs, RF
    PEDIATRIC RESEARCH, 2000, 47 (04) : 221A - 221A
  • [37] Impact of the Updated Guidance for Palivizumab Prophylaxis against Respiratory Syncytial Virus Infection: A Single Center Experience
    Rajah, Bavani
    Sanchez, Pablo J.
    Garcia-Maurino, Cristina
    Leber, Amy
    Ramilo, Octavio
    Mejias, Asuncion
    JOURNAL OF PEDIATRICS, 2017, 181 : 183 - +
  • [38] Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
    Antepowicz, A.
    Kirsebom, F.
    Johansson, C.
    Gill, D. R.
    Hyde, S. C.
    HUMAN GENE THERAPY, 2018, 29 (12) : A118 - A118
  • [39] Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants
    Vogel, AM
    Lennon, DR
    Broadbent, R
    Byrnes, CA
    Grimwood, K
    Mildenhall, L
    Richardson, V
    Rowley, S
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2002, 38 (06) : 550 - 554
  • [40] Consensus paper on prophylaxis against RSV infection with Palivizumab and post-RSV respiratory tract disease
    不详
    MONATSSCHRIFT KINDERHEILKUNDE, 2008, 156 (04) : 381 - 383
12345